<DOC>
	<DOC>NCT02754596</DOC>
	<brief_summary>This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution.</brief_summary>
	<brief_title>Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution</brief_title>
	<detailed_description>This is a randomized trial comparing two elution doses of the Travoprost Intraocular implant to timolol ophthalmic solution in patients with open-angle glaucoma. Study assessments will include IOP and medication use as well as safety parameters.</detailed_description>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Maleic acid</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Open angle glaucoma Uveitic, neovascular, or angle closure glaucoma; or glaucoma associated with vascular disorders. Functionally significant visual field loss, including severe nerve fiber bundle defects. Prior glaucoma surgery. Uncontrolled systemic disease, pregnant females or those planning a pregnancy. Other ocular status conditions, etc.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>